Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Taken together, these studies establish potentially converging disease mechanisms in ALS and spinal muscular atrophy, with ALS-causative mutants acquiring properties representing both gain (dysregulation of SMN) and loss (reduced RNA processing mediated by U1-snRNP) of function.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Taken together, these studies establish potentially converging disease mechanisms in ALS and spinal muscular atrophy, with ALS-causative mutants acquiring properties representing both gain (dysregulation of SMN) and loss (reduced RNA processing mediated by U1-snRNP) of function.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Taken together, these studies establish potentially converging disease mechanisms in ALS and spinal muscular atrophy, with ALS-causative mutants acquiring properties representing both gain (dysregulation of SMN) and loss (reduced RNA processing mediated by U1-snRNP) of function.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Taken together, these studies establish potentially converging disease mechanisms in ALS and spinal muscular atrophy, with ALS-causative mutants acquiring properties representing both gain (dysregulation of SMN) and loss (reduced RNA processing mediated by U1-snRNP) of function.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Taken together, these studies establish potentially converging disease mechanisms in ALS and spinal muscular atrophy, with ALS-causative mutants acquiring properties representing both gain (dysregulation of SMN) and loss (reduced RNA processing mediated by U1-snRNP) of function.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Taken together, these studies establish potentially converging disease mechanisms in ALS and spinal muscular atrophy, with ALS-causative mutants acquiring properties representing both gain (dysregulation of SMN) and loss (reduced RNA processing mediated by U1-snRNP) of function.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Taken together, these studies establish potentially converging disease mechanisms in ALS and spinal muscular atrophy, with ALS-causative mutants acquiring properties representing both gain (dysregulation of SMN) and loss (reduced RNA processing mediated by U1-snRNP) of function.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Taken together, these studies establish potentially converging disease mechanisms in ALS and spinal muscular atrophy, with ALS-causative mutants acquiring properties representing both gain (dysregulation of SMN) and loss (reduced RNA processing mediated by U1-snRNP) of function.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Taken together, these studies establish potentially converging disease mechanisms in ALS and spinal muscular atrophy, with ALS-causative mutants acquiring properties representing both gain (dysregulation of SMN) and loss (reduced RNA processing mediated by U1-snRNP) of function.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Taken together, these studies establish potentially converging disease mechanisms in ALS and spinal muscular atrophy, with ALS-causative mutants acquiring properties representing both gain (dysregulation of SMN) and loss (reduced RNA processing mediated by U1-snRNP) of function.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Taken together, these studies establish potentially converging disease mechanisms in ALS and spinal muscular atrophy, with ALS-causative mutants acquiring properties representing both gain (dysregulation of SMN) and loss (reduced RNA processing mediated by U1-snRNP) of function.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1258809.RASKmjJ_6bcp_5GY7s6pJp03LUNXRe1RFzpZs9wE79KYc130_assertion description "[Taken together, these studies establish potentially converging disease mechanisms in ALS and spinal muscular atrophy, with ALS-causative mutants acquiring properties representing both gain (dysregulation of SMN) and loss (reduced RNA processing mediated by U1-snRNP) of function.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1258809.RASKmjJ_6bcp_5GY7s6pJp03LUNXRe1RFzpZs9wE79KYc130_provenance.
• NP1258815.RAZh8VKX_fRvtEWTjGHYf5G7ByPMDUirom-l3ydxZ-_fs130_assertion description "[Taken together, these studies establish potentially converging disease mechanisms in ALS and spinal muscular atrophy, with ALS-causative mutants acquiring properties representing both gain (dysregulation of SMN) and loss (reduced RNA processing mediated by U1-snRNP) of function.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1258815.RAZh8VKX_fRvtEWTjGHYf5G7ByPMDUirom-l3ydxZ-_fs130_provenance.
• assertion description "[Taken together, these studies establish potentially converging disease mechanisms in ALS and spinal muscular atrophy, with ALS-causative mutants acquiring properties representing both gain (dysregulation of SMN) and loss (reduced RNA processing mediated by U1-snRNP) of function.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1258816.RAsaU6AerImhx-lij4RbfufrTlm-5zqn6CO6JksD-RnUw130_assertion description "[Taken together, these studies establish potentially converging disease mechanisms in ALS and spinal muscular atrophy, with ALS-causative mutants acquiring properties representing both gain (dysregulation of SMN) and loss (reduced RNA processing mediated by U1-snRNP) of function.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1258816.RAsaU6AerImhx-lij4RbfufrTlm-5zqn6CO6JksD-RnUw130_provenance.
• NP1258811.RAOfmciu24Kaidh0WYThy8HASlNwhdjFr3QED2Y8me2K8130_assertion description "[Taken together, these studies establish potentially converging disease mechanisms in ALS and spinal muscular atrophy, with ALS-causative mutants acquiring properties representing both gain (dysregulation of SMN) and loss (reduced RNA processing mediated by U1-snRNP) of function.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1258811.RAOfmciu24Kaidh0WYThy8HASlNwhdjFr3QED2Y8me2K8130_provenance.
• NP1258813.RAEJ4ANtz8Vs_GuNbapFSlDFIC-_cqWuvwLNkp8dzoEMM130_assertion description "[Taken together, these studies establish potentially converging disease mechanisms in ALS and spinal muscular atrophy, with ALS-causative mutants acquiring properties representing both gain (dysregulation of SMN) and loss (reduced RNA processing mediated by U1-snRNP) of function.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1258813.RAEJ4ANtz8Vs_GuNbapFSlDFIC-_cqWuvwLNkp8dzoEMM130_provenance.
• NP1258817.RAMDidFaEr94eLBBa4T1caci1dGy8qiVOz0PU_GDxkZ1E130_assertion description "[Taken together, these studies establish potentially converging disease mechanisms in ALS and spinal muscular atrophy, with ALS-causative mutants acquiring properties representing both gain (dysregulation of SMN) and loss (reduced RNA processing mediated by U1-snRNP) of function.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1258817.RAMDidFaEr94eLBBa4T1caci1dGy8qiVOz0PU_GDxkZ1E130_provenance.
• NP1258810.RA1S-GYwqBwpnTzgK16IDPiqaPBaJ2kW9vz-q8Q3Fv_xQ130_assertion description "[Taken together, these studies establish potentially converging disease mechanisms in ALS and spinal muscular atrophy, with ALS-causative mutants acquiring properties representing both gain (dysregulation of SMN) and loss (reduced RNA processing mediated by U1-snRNP) of function.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1258810.RA1S-GYwqBwpnTzgK16IDPiqaPBaJ2kW9vz-q8Q3Fv_xQ130_provenance.
• NP1258812.RA4fVo69GelEsv5CZKQKyIzS6796hbn-rbpqUnPaxm2r8130_assertion description "[Taken together, these studies establish potentially converging disease mechanisms in ALS and spinal muscular atrophy, with ALS-causative mutants acquiring properties representing both gain (dysregulation of SMN) and loss (reduced RNA processing mediated by U1-snRNP) of function.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1258812.RA4fVo69GelEsv5CZKQKyIzS6796hbn-rbpqUnPaxm2r8130_provenance.
• NP1258818.RAw6N9WFxkHPflA_SyIjGIO5HOZoBwlY3xAVlRH-4l6TI130_assertion description "[Taken together, these studies establish potentially converging disease mechanisms in ALS and spinal muscular atrophy, with ALS-causative mutants acquiring properties representing both gain (dysregulation of SMN) and loss (reduced RNA processing mediated by U1-snRNP) of function.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1258818.RAw6N9WFxkHPflA_SyIjGIO5HOZoBwlY3xAVlRH-4l6TI130_provenance.
• NP1258819.RAxu_G0GOTe75whbmMm86gSVtTH-dr8zHVmMZPrjkuJzw130_assertion description "[Taken together, these studies establish potentially converging disease mechanisms in ALS and spinal muscular atrophy, with ALS-causative mutants acquiring properties representing both gain (dysregulation of SMN) and loss (reduced RNA processing mediated by U1-snRNP) of function.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1258819.RAxu_G0GOTe75whbmMm86gSVtTH-dr8zHVmMZPrjkuJzw130_provenance.